Literature DB >> 8287318

Bone endothelial cells as estrogen targets.

M L Brandi1, C Crescioli, A Tanini, U Frediani, D Agnusdei, C Gennari.   

Abstract

In the present study, we investigated the effects of estrogens on bone endothelial cell metabolism and the presence of estrogen binding sites in the same cells. For these studies, we have used a continuous cell line of clonal bovine bone endothelial cells for evidence of a direct response to estrogens in vitro. Receptor analysis to intact viable cells was steroid specific and saturable, with an apparent dissociation constant of 17.2 nM and a Bmax of 3.2 x 10(4) sites/cell. Northern blot analysis revealed a 6.5-kilobase mRNA that hybridized with a cDNA to human estrogen receptor. The 6.5-kilobase size is in close agreement with the reported size of the human estrogen receptor mRNA. In vitro estrogen responses of bone endothelial cells included a stimulation of cell proliferation as well as an inhibition of parathyroid hormone responsiveness. These findings clearly demonstrate the presence of functional estrogen receptors in bone endothelial cells in vitro, suggesting a role of estrogens in bone angiogenesis and in the entire process of bone remodeling.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287318     DOI: 10.1007/BF01351835

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  35 in total

1.  Osteoclasts isolated from membranous bone in children exhibit nuclear estrogen and progesterone receptors.

Authors:  J M Pensler; J A Radosevich; R Higbee; C B Langman
Journal:  J Bone Miner Res       Date:  1990-08       Impact factor: 6.741

Review 2.  Radioimmunoassay of cyclic AMP and cyclic GMP.

Authors:  G Brooker; J F Harper; W L Terasaki; R D Moylan
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

3.  Bone blood flow and in vitro proliferation of bone marrow and trabecular bone osteoblast-like cells in ovariectomized rats.

Authors:  D Egrise; D Martin; P Neve; A Vienne; M Verhas; A Schoutens
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

4.  Cytosol type II sites in the rat uterus: interaction with an endogenous ligand.

Authors:  B M Markaverich; N R Adams; R R Roberts; M Alejandro; J H Clark
Journal:  J Steroid Biochem       Date:  1987-12       Impact factor: 4.292

5.  Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells.

Authors:  B S Komm; C M Terpening; D J Benz; K A Graeme; A Gallegos; M Korc; G L Greene; B W O'Malley; M R Haussler
Journal:  Science       Date:  1988-07-01       Impact factor: 47.728

6.  Osteoblast-like cells in the presence of parathyroid hormone release soluble factor that stimulates osteoclastic bone resorption.

Authors:  P M McSheehy; T J Chambers
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

7.  Immunocytochemical localization of estrogen receptors in the macaque endometrium during the luteal-follicular transition.

Authors:  M McClellan; N B West; R M Brenner
Journal:  Endocrinology       Date:  1986-12       Impact factor: 4.736

8.  Effect of ovarian hormones on the uterine vascular bed.

Authors:  F C Greiss; S G Anderson
Journal:  Am J Obstet Gynecol       Date:  1970-07-15       Impact factor: 8.661

9.  Kinetic alterations in estrogen receptors associated with estrogen receptor processing in human breast cancer cells.

Authors:  J S Strobl; A Kasid; K K Huff; M E Lippman
Journal:  Endocrinology       Date:  1984-09       Impact factor: 4.736

10.  Changes in trabecular bone, hematopoiesis and bone marrow vessels in aplastic anemia, primary osteoporosis, and old age: a comparative histomorphometric study.

Authors:  R Burkhardt; G Kettner; W Böhm; M Schmidmeier; R Schlag; B Frisch; B Mallmann; W Eisenmenger; T Gilg
Journal:  Bone       Date:  1987       Impact factor: 4.398

View more
  9 in total

Review 1.  Skeletal effects of estrogens.

Authors:  G Fiorelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

Review 2.  In vitro models for the evaluation of angiogenic potential in bone engineering.

Authors:  Elisabetta Cenni; Francesca Perut; Nicola Baldini
Journal:  Acta Pharmacol Sin       Date:  2010-11-01       Impact factor: 6.150

Review 3.  Mechanical, hormonal and metabolic influences on blood vessels, blood flow and bone.

Authors:  Rhonda D Prisby
Journal:  J Endocrinol       Date:  2017-08-16       Impact factor: 4.286

4.  Functional estrogen receptors in a human preosteoclastic cell line.

Authors:  G Fiorelli; F Gori; M Petilli; A Tanini; S Benvenuti; M Serio; P Bernabei; M L Brandi
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor.

Authors:  S W McLeskey; C A Tobias; P R Vezza; A C Filie; F G Kern; J Hanfelt
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 6.  Blood Vessels and Vascular Niches in Bone Development and Physiological Remodeling.

Authors:  Michelle Hendriks; Saravana K Ramasamy
Journal:  Front Cell Dev Biol       Date:  2020-11-27

7.  The role of estrogen and progesterone receptors in the rotator cuff disease: a retrospective cohort study.

Authors:  Umile Giuseppe Longo; Alessandro Mazzola; Simone Carotti; Maria Francesconi; Simone Catapano; Francesco Magrì; Giuseppe Perrone; Sergio Morini; Sergio De Salvatore; Vincenzo Denaro
Journal:  BMC Musculoskelet Disord       Date:  2021-10-20       Impact factor: 2.362

8.  Bone vascularization in normal and disease conditions.

Authors:  Christian Carulli; Massimo Innocenti; Maria Luisa Brandi
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-26       Impact factor: 5.555

Review 9.  The role of angiogenesis in implant dentistry part II: The effect of bone-grafting and barrier membrane materials on angiogenesis.

Authors:  M-A Saghiri; A Asatourian; F Garcia-Godoy; N Sheibani
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2016-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.